e-learning
resources
ERS Research Seminars
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oxidant/Antioxidant imbalance: a potential contributor to pulmonary fibrosis
J. Behr (Munich, Germany)
Source:
Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Number:
19
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Behr (Munich, Germany). Oxidant/Antioxidant imbalance: a potential contributor to pulmonary fibrosis. Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Definition and history of sarcoidosis
Related content which might interest you:
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase?
Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Year: 2007
Is TGFb a central mediator in the development of pulmonary fibrosis?
Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar
Year: 2010
Biomarkers in pulmonary fibrosis
Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine
Year: 2011
17(R)-resolvinD1 improves MMP-9/TIMP-1 imbalance leading to amelioration of pulmonary fibrosis in mice
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
LSC 2010 Abstract: Overexpression of Ang-(1-7)-fusion protein in the lungs prevents pulmonary fibrosis and accompanying pulmonary hypertension
Source: Annual Congress 2010 - Pre-clinical models of airways disease
Year: 2010
Increased systemic inflammation in cystic fibrosis (CF) is associated with deterioration in lung clearance index (LCI)
Source: International Congress 2014 – Cystic fibrosis: genotypes, inflammation and microbiology
Year: 2014
Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis
Source: Eur Respir J 2015; 46: 1084-1094
Year: 2015
Possible role of liver disease and respiratory insufficiency in osteopenia in cystic fibrosis patients
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013
Aerobic exercise reduces lung inflammation and fibrosis mediated by serotoninergic/Akt signaling in a model of pulmonary fibrosis
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Infant pulmonary function - Multiple Breath Washout
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006
Cystic fibrosis related pulmonary disease: more structure than function?
Source: Eur Respir J 2005; 26: Suppl. 49, 729s
Year: 2005
Dysregulated ECM stability: A pathomechanism in chronic obstructive pulmonary disease?
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010
Pulmonary expression of alternatively spliced tissue factor as a potential prognostic marker in idiopathic pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Factor contributing to peak VO
2
in idiopathic pulmonary fibrosis: in comparison with COPD
Source: Annual Congress 2007 - Assessment and outcomes in non-COPD patients
Year: 2007
Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF)
Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation
Year: 2011
Interdependence of HIF1alpha /TGFbeta1 activity in induction of pulmonary fibrosis
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Vascular remodelling in pulmonary hypertension: A role for matrix cross-linking?
Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Year: 2010
Increased levels of oxidative stress markers in patients with idiopathic pulmonary fibrosis
Source: International Congress 2016 – Common mechanisms in lung development and fibrosis
Year: 2016
Club cell secretory protein-CC16 is increased in idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept